Federal and state regulators asked a judge to hold “pharma bro” Martin Shkreli in contempt, alleging he traded drug stocks despite a lifetime ban from the pharmaceutical industry

Regulators allege the ex-drug executive held more than 60 pharmaceutical stocks despite a court order barring him from the industry.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。